Survival benefits of metformin in non-diabetics: faulty analysis in a 2014 study
Science Media Centre - 08-Aug-2014It's not logical to advise people without diabetes to take metformin
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Professor of Pharmacoepidemiology at Cardiff University and director at Pharmatelligence
Experienced consultant in all aspects of medicines evaluation: epidemiology, economics, stats, database analysis and reimbursement strategy.
Specialties: Drug evaluation, device evaluation, drug reimbursement, epidemiology, health economics, medical statistics, clinical trial design, health services research, consultancy, business devotement, large database analysis (GPRD, THIN HES, clinical trials data).
Diseases of particular interest: cardiovascular disease, diabetes, inflammatory disease, dermatological diseases.
Details last updated 30-May-2020
It's not logical to advise people without diabetes to take metformin